Arpeggio: A Web Server for Calculating and Visualising Interatomic Interactions in Protein Structures

Journal of Molecular Biology

Volumn 429, Issue 3, 2017, Pages 365-371

  Jubb, Harry C ^a,c   Higueruelo, Alicia P ^a,d   Ochoa Montaño, Bernardo ^a   Pitt, Will R ^b   Ascher, David B ^a,e   Blundell, Tom L ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UCB Celltech   (United Kingdom)

^c WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^d CAMBRIDGE CRYSTALLOGRAPHIC DATA CENTRE   (United Kingdom)

^e UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

drug design; molecular recognition; protein interactions; protein ligand interactions; protein protein interactions

Indexed keywords

CARBON; CARBONYL DERIVATIVE; DNA; HALOGEN; METAL; PROTEIN;

ARPEGGIO; ARTICLE; CALCULATION; CHEMICAL BOND; CHEMICAL STRUCTURE; DONOR; HYDROGEN BOND; HYDROPHOBICITY; IMAGE QUALITY; MACROMOLECULE; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN STRUCTURE; SOFTWARE; AMINO ACID SEQUENCE; CHEMISTRY; COMPUTER INTERFACE; DNA SEQUENCE; INTERNET; MOLECULAR CLONING; PROTEIN DATABASE; PROTEIN TERTIARY STRUCTURE;

AMINO ACID SEQUENCE; CLONING, MOLECULAR; DATABASES, PROTEIN; INTERNET; PROTEIN STRUCTURE, TERTIARY; PROTEINS; SEQUENCE ANALYSIS, DNA; USER-COMPUTER INTERFACE;

EID: 85009250602     PISSN: 00222836     EISSN: 10898638     Source Type: Journal    
DOI: 10.1016/j.jmb.2016.12.004     Document Type: Article

References (38)

1. [1] Allen, F.H., Baalham, C.A., Lommerse, J.P.M., Raithby, P.R., Carbonyl–carbonyl interactions can be competitive with hydrogen bonds. Acta Crystallogr. B 54 (1998), 320–329.
2. [2] Chakrabarti, P., Bhattacharyya, R., Geometry of nonbonded interactions involving planar groups in proteins. Prog. Biophys. Mol. Biol. 95 (2007), 83–137.
3. [3] Lu, Y., Shi, T., Wang, Y., Yang, H., Yan, X., Luo, X., et al. Halogen bonding—a novel interaction for rational drug design?. J. Med. Chem. 52 (2009), 2854–2862.
4. [4] Ma, J.C., Dougherty, D.A., The cation–pi interaction. Chem. Rev. 97 (1997), 1303–1324.
5. [5] McDonald, I.K., Thornton, J.M., Satisfying hydrogen bonding potential in proteins. J. Mol. Biol. 238 (1994), 777–793.
6. [6] McGaughey, G.B., Gagne, M., Rappe, A.K., Pi-stacking interactions. Alive and well in proteins. J. Biol. Chem. 273 (1998), 15,458–15,463.
7. [7] Baker, E.N., Hubbard, R.E., Hydrogen bonding in globular proteins. Prog. Biophys. Mol. Biol. 44 (1984), 97–179.
8. [8] Jubb, H., Blundell, T.L., Ascher, D.B., Flexibility and small pockets at protein–protein interfaces: new insights into druggability. Prog. Biophys. Mol. Biol. 119 (2015), 2–9.
9. [9] Kasahara, K., Kinoshita, K., GIANT: pattern analysis of molecular interactions in 3D structures of protein-small ligand complexes. BMC Bioinformatics, 15, 2014, 12.
10. [10] Sobolev, V., Sorokine, A., Prilusky, J., Abola, E.E., Edelman, M., Automated analysis of interatomic contacts in proteins. Bioinformatics 15 (1999), 327–332.
11. [11] Mizuguchi, K., Deane, C.M., Blundell, T.L., Johnson, M.S., Overington, J.P., JOY: protein sequence-structure representation and analysis. Bioinformatics 14 (1998), 617–623.
12. [12] Word, J.M., Lovell, S.C., Richardson, J.S., Richardson, D.C., Asparagine and glutamine: using hydrogen atom contacts in the choice of side-chain amide orientation. J. Mol. Biol. 285 (1999), 1735–1747.
13. [13] Porter, C.T., Martin, A.C., BiopLib and BiopTools—a C programming library and toolset for manipulating protein structure. Bioinformatics 31 (2015), 4017–4019.
14. [14] Laskowski, R.A., Swindells, M.B., LigPlot +: multiple ligand–protein interaction diagrams for drug discovery. J. Chem. Inf. Model. 51 (2011), 2778–2786.
15. [15] Marcou, G., Rognan, D., Optimizing fragment and scaffold docking by use of molecular interaction fingerprints. J. Chem. Inf. Model. 47 (2007), 195–207.
16. [16] Radifar, M., Yuniarti, N., Istyastono, E.P., PyPLIF: python-based protein-ligand interaction fingerprinting. Bioinformation 9 (2013), 325–328.
17. [17] Salentin, S., Schreiber, S., Haupt, V.J., Adasme, M.F., Schroeder, M., PLIP: fully automated protein-ligand interaction profiler. Nucleic Acids Res. 43 (2015), W443–W447.
18. [18] Berman, H., Henrick, K., Nakamura, H., Markley, J.L., The worldwide Protein Data Bank (wwPDB): ensuring a single, uniform archive of PDB data. Nucleic Acids Res. 35 (2007), D301–D303.
19. [19] Schreyer, A., Blundell, T., CREDO: a protein–ligand interaction database for drug discovery. Chem. Biol. Drug Des. 73 (2009), 157–167.
20. [20] Bickerton, G.R., Higueruelo, A.P., Blundell, T.L., Comprehensive, atomic-level characterization of structurally characterized protein–protein interactions: the PICCOLO database. BMC Bioinformatics, 12, 2011, 313.
21. [21] Higueruelo, A.P., Schreyer, A., Bickerton, G.R., Pitt, W.R., Groom, C.R., Blundell, T.L., Atomic interactions and profile of small molecules disrupting protein–protein interfaces: the TIMBAL database. Chem. Biol. Drug Des. 74 (2009), 457–467.
22. [22] Lee, S., Blundell, T.L., BIPA: a database for protein-nucleic acid interaction in 3D structures. Bioinformatics 25 (2009), 1559–1560.
23. [23] Schreyer, A.M., Blundell, T.L., CREDO: a structural interactomics database for drug discovery. Database (Oxford), 2013, 2013, bat049.
24. [24] Cock, P.J., Antao, T., Chang, J.T., Chapman, B.A., Cox, C.J., Dalke, A., et al. Biopython: freely available python tools for computational molecular biology and bioinformatics. Bioinformatics 25 (2009), 1422–1423.
25. [25] O'Boyle, N.M., Banck, M., James, C.A., Morley, C., Vandermeersch, T., Hutchison, G.R., Open Babel: an open chemical toolbox. J Cheminform., 3, 2011, 33.
26. [26] Deng, Z., Chuaqui, C., Singh, J., Structural interaction fingerprint (SIFt): a novel method for analyzing three-dimensional protein–ligand binding interactions. J. Med. Chem. 47 (2004), 337–344.
27. [27] Burley, S.K., Petsko, G.A., Amino-aromatic interactions in proteins. FEBS Lett. 203 (1986), 139–143.
28. [28] Zhou, P., Tian, F., Lv, F., Shang, Z., Geometric characteristics of hydrogen bonds involving sulfur atoms in proteins. Proteins 76 (2009), 151–163.
29. [29] Valley, C.C., Cembran, A., Perlmutter, J.D., Lewis, A.K., Labello, N.P., Gao, J., et al. The methionine-aromatic motif plays a unique role in stabilizing protein structure. J. Biol. Chem. 287 (2012), 34,979–34,991.
30. [30] Biswal, H.S., Gloaguen, E., Loquais, Y., Tardivel, B., Mons, M., Strength of NH…S hydrogen bonds in methionine residues revealed by gas-phase IR/UV spectroscopy. J. Phys. Chem. Lett. 3 (2012), 755–759.
31. [31] Pires, D.E., Chen, J., Blundell, T.L., Ascher, D.B., In silico functional dissection of saturation mutagenesis: interpreting the relationship between phenotypes and changes in protein stability, interactions and activity. Sci. Rep., 6, 2016, 19,848.
32. [32] Nemethova, M., Radvanszky, J., Kadasi, L., Ascher, D.B., Pires, D.E., Blundell, T.L., et al. Twelve novel HGD gene variants identified in 99 alkaptonuria patients: focus on ‘black bone disease’ in Italy. Eur. J. Hum. Genet. 24 (2016), 66–72.
33. [33] Jafri, M., Wake, N.C., Ascher, D.B., Pires, D.E., Gentle, D., Morris, M.R., et al. Germline mutations in the CDKN2B tumor suppressor gene predispose to renal cell carcinoma. Cancer Discov. 5 (2015), 723–729.
34. [34] Usher, J.L., Ascher, D.B., Pires, D.E., Milan, A.M., Blundell, T.L., Ranganath, L.R., Analysis of HGD Gene mutations in patients with alkaptonuria from the United Kingdom: identification of novel mutations. JIMD Rep. 24 (2015), 3–11.
35. [35] Pires, D.E., Blundell, T.L., Ascher, D.B., Platinum: a database of experimentally measured effects of mutations on structurally defined protein–ligand complexes. Nucleic Acids Res. 43 (2015), D387–D391.
36. [36] Phelan, J., Coll, F., McNerney, R., Ascher, D.B., Pires, D.E., Furnham, N., et al. Mycobacterium tuberculosis whole genome sequencing and protein structure modelling provides insights into anti-tuberculosis drug resistance. BMC Med., 14, 2016, 31.
37. [37] Park, Y., Pacitto, A., Bayliss, T., Cleghorn, L.A.T., Wang, Z., Hartman, T., et al. Essential but not vulnerable: indazole sulfonamides targeting inosine monophosphate dehydrogenase as potential leads against Mycobacterium tuberculosis. ACS Infect. Dis., 2016 (Epub ahead of print).
38. [38] Singh, V., Donini, S., Pacitto, A., Sala, C., Hartkoorn, R.C., Dhar, N., et al. The inosine monophosphate dehydrogenase, GuaB2, is a vulnerable new bactericidal drug target for tuberculosis. ACS Infect. Dis., 2016 (Epub ahead of print).